Neurofibromatosis Type 1: Clinical and Molecular Characterization in a Romanian Cohort of 80 Patients
Diagnostics · 02.11.2026 · 16 (21) · 3618
DOI: 10.3390/diagnostics16213618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 02.11.2026. Verfasst von Ionut Gavrila und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Genomics, University of Medicine and Pharmacy of Craiova, 200638 Craiova, Romania. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor-predisposition disorder with age-dependent manifestations and marked clinical variability. This study characterized clinical observations and documented molecular findings in a Romanian regional referral cohort.
Methods
We retrospectively analyzed 80 patients referred between 2017 and 2025 because of a family history of NF1 or suggestive clinical signs. Available next-generation sequencing (NGS) and multiplex ligation-dependent probe amplification (MLPA) results were reviewed, and variants were classified according to ACMG/AMP criteria.
Results
Pathogenic or likely pathogenic NF1 variants were reported in 15/80 patients (18.75%): 13/66 children (19.7%) and 2/14 adults (14.3%). Five sequence variants and ten copy-number deletions were identified. Clinical observations included pigmentary, neurodevelopmental, skeletal, dysmorphic, and tumor-related findings. Testing availability and clinical documentation were heterogeneous.
Conclusions
The detected molecular spectrum included both sequence and dosage variants. Uneven assay availability limits estimation of the incremental yield of combined testing. Complete diagnostic documentation and age-appropriate follow-up are important for interpreting molecular findings and supporting family counseling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Human Genomics, University of Medicine and Pharmacy of Craiova, 200638 Craiova, Romania.
- Human Genomics Laboratory-Research Center for Gastroenterology and Hepatology (CCGH), Craiova-University of Medicine and Pharmacy of Craiova, 200638 Craiova, Romania.
- Clinical Neuroscience Department, Pediatric Neurology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Department of Pediatric Neurology, Prof. Dr. Alex. Obregia Clinical Hospital of Psychiatry, 041914 Bucharest, Romania.
- "Dr. Victor Gomoiu" Clinical Children's Hospital, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Research Methodology Department, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
ORCID-Profile: Răzvan Mihail Pleșea, Mihai Gabriel Cucu, Raluca-Ioana Teleanu, Cristian Gheonea
Zitieren
APA
Gavrila, I., Riza, A. L., Pleșea, R. M., Serban, R. C., Cucu, M. G., Roza, E., Budisteanu, M., Teleanu, R. I., Varut, R. M., Gheonea, C., Burada, F., & Streata, I. (2026). Neurofibromatosis Type 1: Clinical and Molecular Characterization in a Romanian Cohort of 80 Patients. Diagnostics, 16(21), 3618. https://doi.org/10.3390/diagnostics16213618
Vancouver
Gavrila I, Riza AL, Pleșea RM, Serban RC, Cucu MG, Roza E, et al. Neurofibromatosis Type 1: Clinical and Molecular Characterization in a Romanian Cohort of 80 Patients. Diagnostics. 2026;16(21):3618. doi:10.3390/diagnostics16213618
BibTeX
@article{Gavrila2026,
author = {Gavrila, Ionut and Riza, Anca-Lelia and Pleșea, Răzvan Mihail and Serban, Rebecca-Cristiana and Cucu, Mihai Gabriel and Roza, Eugenia and Budisteanu, Magdalena and Teleanu, Raluca-Ioana and Varut, Renata Maria and Gheonea, Cristian and Burada, Florin and Streata, Ioana},
title = {Neurofibromatosis Type 1: Clinical and Molecular Characterization in a Romanian Cohort of 80 Patients},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {21},
pages = {3618},
doi = {10.3390/diagnostics16213618}
}
EUVIMED